.svg){kind=small}
Market Insights Snapshot
In May 2026, Farmaceutical Rx (Frx) remained concentrated in Flower at 73.89% share while that category fell 85.21% year over year and 35.45% month over month, pulling the brand’s overall sales down 82.50% YoY and lowering average price 13.12% YoY. Offsets came from Edible at 16.86% share with 31.57% MoM growth despite a 75.88% YoY decline, and Concentrates at 5.03% share posting 470.73% YoY and 23.05% MoM growth; meanwhile Beverage held 1.47% share with 67.99% YoY growth but slipped 8.24% MoM, and Vapor Pens at 0.11% share dropped 46.27% MoM. The mix indicates overdependence on a contracting Flower base and an emerging pivot toward higher-growth niches, implying that near-term stability depends on accelerating the Edible and Concentrates contribution while managing price and volume in Flower.
These shifts reposition Farmaceutical Rx (Frx) from a Flower-led profile toward a more diversified basket where Edible and Concentrates momentum can buffer volatility, but the 57 rank in Flower in Ohio and a 35.45% MoM Flower decline signal limited headroom if the current mix persists. Given Concentrates’ 470.73% YoY surge at a $44.86 average price and Edible’s 31.57% MoM uptick at a $29.80 average price, the brand’s path to steadier share rests on reallocating assortment and shelf focus toward these faster-moving formats while using targeted price architecture to slow the 13.12% YoY price erosion and the 8.24% MoM Beverage dip.
Competitive Landscape
Farmaceutical Rx (Frx) sits at rank #57 in OH Flower for May 2026, down 34 places year over year from #23, and off 1 position from February 2026’s #56, indicating a sustained slide since its peak at #13 in July 2024. By contrast, Riviera Creek held #1 while dropping 1 place YoY from #2 and posting a 10.1% YoY sales decline, and RYTHM moved up 5 places to #2 from #7 with 49.2% YoY sales growth, while Klutch Cannabis climbed 13 places to #3 from #16 with 161.1% YoY sales growth; this divergence implies Farmaceutical Rx (Frx)’s current rank trajectory signals share ceding to faster-moving leaders rather than cyclical noise.
Notable Products
Pineapple Kush (3.5g) posted the steepest decline at -17.5% MoM and slid to rank 7, while Banana Kush (2.83g) dropped -44.4% MoM to rank 8, indicating strain-specific pressure within mid-tier Flower. At the top, Milkbone (3.5g) held rank 1 and Banana Kush (3.5g) stayed near the top at rank 2 with a -3.7% MoM dip, placing two Flower SKUs in the top two despite weakness deeper in the lineup. Four of the top ten are Flower SKUs by rank positions 1, 2, 3, and 5, while the highest non-Flower entry Razzleberry Gummies 10-Pack (330mg) sits at rank 4, implying diversification is cushioning volatility from sub-eighth Flower formats. The pattern implies Farmaceutical Rx (Frx) is consolidating around flagship eighths while downsizing exposure to smaller-size Flower that is underperforming.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
